Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000345641 | SCV000377768 | likely benign | Timothy syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000390000 | SCV000377769 | likely benign | Brugada syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000436421 | SCV000518603 | benign | not specified | 2015-09-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000552154 | SCV000627576 | likely benign | Long QT syndrome | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000436421 | SCV002600823 | benign | not specified | 2022-10-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356419 | SCV002647954 | likely benign | Cardiovascular phenotype | 2022-07-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |